+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

MiMedx Group Inc (MDXG) - Product Pipeline Analysis, 2020 Update

  • ID: 5240120
  • Company Profile
  • January 2021
  • 42 pages
  • GlobalData

FEATURED COMPANIES

  • Acceleron Pharma Inc
  • Biolife Solutions Inc
  • Merakris Therapeutics LLC
  • Osiris Therapeutics Inc
  • StimLabs LLC
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation, and enhance healing. The company offers services in the areas of wound care, burn, surgical, orthopaedic, spine, sports medicine, ophthalmic and dental sectors of healthcare. MiMedx is headquartered in Marietta, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MiMedx Group Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Acceleron Pharma Inc
  • Biolife Solutions Inc
  • Merakris Therapeutics LLC
  • Osiris Therapeutics Inc
  • StimLabs LLC
MiMedx Group Inc Company Overview
  • MiMedx Group Inc Company Snapshot
  • MiMedx Group Inc Pipeline Products and Ongoing Clinical Trials Overview
  • MiMedx Group Inc - Pipeline Analysis Overview
  • MiMedx Group Inc - Key Facts
  • MiMedx Group Inc - Major Products and Services
  • MiMedx Group Inc Pipeline Products by Development Stage
  • MiMedx Group Inc Ongoing Clinical Trials by Trial Status
MiMedx Group Inc Pipeline Products Overview
  • AmnioFix Injectable - Achilles Tendonitis
  • AmnioFix Injectable - Achilles Tendonitis Product Overview
  • AmnioFix Injectable - Achilles Tendonitis Clinical Trial
  • AmnioFix Injectable - Knee OA Pain
  • AmnioFix Injectable - Knee OA Pain Product Overview
  • AmnioFix Injectable - Knee OA Pain Clinical Trial
  • AmnioFix Injectable - Plantar Fasciitis
  • AmnioFix Injectable - Plantar Fasciitis Product Overview
  • AmnioFix Injectable - Plantar Fasciitis Clinical Trial
  • AmnioFix Injectable - Pressure Ulcer
  • AmnioFix Injectable - Pressure Ulcer Product Overview
  • CollaFix - Foot & Ankle
  • CollaFix - Foot & Ankle Product Overview
  • CollaFix - Rotator Cuff Repair
  • CollaFix - Rotator Cuff Repair Product Overview
  • CollaFix BioBraid
  • CollaFix BioBraid Product Overview
  • CollaFix Collagen Fiber Suture
  • CollaFix Collagen Fiber Suture Product Overview
  • CollaFix Tendon Protector
  • CollaFix Tendon Protector Product Overview
  • EpiFix Amniotic Membrane Allograft
  • EpiFix Amniotic Membrane Allograft Product Overview
  • EpiFix Amniotic Membrane Allograft Clinical Trial
  • SaluDisc
  • SaluDisc Product Overview
MiMedx Group Inc - Key Competitors

MiMedx Group Inc - Key Employees

MiMedx Group Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • MiMedx Group Inc, Recent Developments
  • Jul 28, 2020: MiMedx adds Rohit Kashyap, Ph.D., to leadership team as Executive Vice President and Chief Commercial Officer
  • Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures
  • Dec 16, 2019: MiMedx Announces addition of Peter M. Carlson
  • Nov 26, 2019: SEC charges biotech company and executives with accounting fraud
  • Nov 26, 2019: MiMedx names William Butch Hulse as General Counsel and Secretary
  • Nov 26, 2019: MiMedx announces Securities and Exchange Commission Settlement
  • Sep 20, 2019: MiMedx announces resignation of board member
  • Jun 05, 2019: MiMedx issues new presentation for investors in advance Of 2018 Annual Meeting
  • May 30, 2019: MiMedx announces comprehensive board refreshment plan in cooperation with prescience point
  • May 09, 2019: MiMedx appoints Timothy R. Wright as Chief Executive Officer
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • MiMedx Group Inc Pipeline Products and Ongoing Clinical Trials Overview
  • MiMedx Group Inc Pipeline Products by Equipment Type
  • MiMedx Group Inc Pipeline Products by Indication
  • MiMedx Group Inc Ongoing Clinical Trials by Trial Status
  • MiMedx Group Inc, Key Facts
  • MiMedx Group Inc, Major Products and Services
  • MiMedx Group Inc Number of Pipeline Products by Development Stage
  • MiMedx Group Inc Pipeline Products Summary by Development Stage
  • MiMedx Group Inc Ongoing Clinical Trials by Trial Status
  • MiMedx Group Inc Ongoing Clinical Trials Summary
  • AmnioFix Injectable - Achilles Tendonitis - Product Status
  • AmnioFix Injectable - Achilles Tendonitis - Product Description
  • AmnioFix Injectable - Achilles Tendonitis - A Phase III Achilles Tendonitis Clinical Study of Investigational New Drug (IND)
  • AmnioFix Injectable - Knee OA Pain - Product Status
  • AmnioFix Injectable - Knee OA Pain - Product Description
  • AmnioFix Injectable - Knee OA Pain - A Phase IIb, Prospective, Double-blinded, Randomized Controlled Study of Regenerative Medicine Advanced Therapy (RMAT) Designated AmnioFix Injectable in the Treatment of Knee Osteoarthritis
  • AmnioFix Injectable - Plantar Fasciitis - Product Status
  • AmnioFix Injectable - Plantar Fasciitis - Product Description
  • AmnioFix Injectable - Plantar Fasciitis - Prospective, Double-blinded, Randomized Controlled Trial of AmnioFix Injectable as Compared to a Saline Placebo Injection in the Treatment of Plantar Fasciitis
  • AmnioFix Injectable - Pressure Ulcer - Product Status
  • AmnioFix Injectable - Pressure Ulcer - Product Description
  • CollaFix - Foot & Ankle - Product Status
  • CollaFix - Foot & Ankle - Product Description
  • CollaFix - Rotator Cuff Repair - Product Status
  • CollaFix - Rotator Cuff Repair - Product Description
  • CollaFix BioBraid - Product Status
  • CollaFix BioBraid - Product Description
  • CollaFix Collagen Fiber Suture - Product Status
  • CollaFix Collagen Fiber Suture - Product Description
  • CollaFix Tendon Protector - Product Status
  • CollaFix Tendon Protector - Product Description
  • EpiFix Amniotic Membrane Allograft - Product Status
  • EpiFix Amniotic Membrane Allograft - Product Description
  • EpiFix Amniotic Membrane Allograft - Clinical Evaluation of EpiFix in venous leg ulcers ( VLUs )
  • EpiFix Amniotic Membrane Allograft - Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane
  • EpiFix Amniotic Membrane Allograft - The Registry of Cellular and Tissue Based Therapies for Chronic Wounds and Ulcers
  • SaluDisc - Product Status
  • SaluDisc - Product Description
  • MiMedx Group Inc, Key Employees
  • MiMedx Group Inc, Subsidiaries
  • Glossary
List of Figures
  • MiMedx Group Inc Pipeline Products by Equipment Type
  • MiMedx Group Inc Pipeline Products by Development Stage
  • MiMedx Group Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • StimLabs LLC
  • Osiris Therapeutics Inc
  • Merakris Therapeutics LLC
  • Biolife Solutions Inc
  • Acceleron Pharma Inc
Note: Product cover images may vary from those shown
Adroll
adroll